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Abstract Axenfeld–Rieger syndrome (ARS) is a disorder af-
fecting the anterior segment of the eye, often leading to second-
ary glaucoma and several systemic malformations. It is
inherited in an autosomal dominant fashion that has been asso-
ciatedwith genetic defects inPITX2 andFOXC1. Known genes
CYP1b1, PITX2, and FOXC1 were excluded by Sanger se-
quencing. The purpose of current study is to identify the under-
lying genetic causes in ARS family by whole exome sequenc-
ing (WES). WES was performed for affected proband of fam-
ily, and variants were prioritized based on in silico analyses.
Segregation analysis of candidate variants was performed in
family members. A novel heterozygous PRDM5missense var-
iant (c.877A>G; p.Lys293Glu) was found to segregate with the
disease in an autosomal dominant fashion. The novel missense
variant was absent from population-matched controls, the Ex-
ome Variant Server, and an in-house exome variant database.
The Lys293Glu variant is predicted to be pathogenic and affects
a lysine residue that is conserved in different species. Variants
in the PRDM5 gene were previously identified in anterior seg-
ment defects, i.e., autosomal recessive brittle cornea syndrome
and keratoconus. The results of this study suggest that genetic
variants in PRDM5 can lead to various syndromic and nonsyn-
dromic disorders affecting the anterior segment of the eye.
Keywords Axenfeld–Rieger syndrome .Whole exome
sequencing . PRDM5
Introduction
Axenfeld–Rieger Syndrome (ARS; OMIM 180500) is a rare
developmental disorder inherited in an autosomal dominant
manner with an incidence of 1:200,000. ARS is a part of
phenotypically heterogeneous group of conditions involving
anterior segment dysgenesis, constituting a wide spectrum of
developmental anomalies that may affect the cornea, iris, lens,
and angle [1]. ARS is characterized by a broad range of ab-
normalities, with evident ocular and systemic manifestations.
Ocular features observed in ARS patients include iris stro-
mal hypoplasia, polycoria, corectopia, iridogoniodysgenesis,
posterior embryotoxon, and iris strands bridging the
iridocorneal angle to the trabecular meshwork [2]. Increased
ocular pressure (IOP) leading to glaucoma is the major conse-
quence of the anterior segment dysgenesis observed in ARS,
with approximately half of the patients developing secondary
glaucoma [3]. In addition, ARS patients sometimes present
with various systemic abnormalities including facial
dysmorphisms (e.g., hypertelorism, telecanthus, maxillary hy-
poplasia with flattening of the mid-face, prominent forehead,
and a broad, flat nasal bridge) and dental abnormalities (e.g.,
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microdontia or hypodontia). In the abdominal region, a failure
of involution of the skin results in redundant periumbilical
skin. Hypospadia in males, anal stenosis, pituitary abnormal-
ities, and growth retardation may also be observed. Systemic
changes other than these are usually not considered as the
classical features of ARS [4].
ARS has been associated with mutations in the pituitary
homeobox 2 (PITX2; OMIM 601542) gene at 4q25 [5], and
the forkhead box C1 (FOXC1; OMIM 601090) gene at 6p25
[6, 7]. A third locus was suggested on 13q14, but a disease-
causing gene has not yet been identified [8, 9]. In two isolated
ARS cases, deletion of the 16q23-q24 region [10] and deletion
of the PAX6 gene at 11p13 [11] have been reported.
The goal of this study was to identify the underlying ge-
netic cause in an autosomal dominant ARS family by whole
exome sequencing (WES).
Methods
Clinical evaluation
A Pakistani family of Punjabi origin with four affected indi-
viduals was included in the study (Fig. 1). The study adhered
to the principles of the declaration of Helsinki and was ap-
proved by the institutional ethical review board of Al-Shifa
Eye Trust Hospital in Rawalpindi. Blood samples were drawn
from affected and unaffected family members, after obtaining
written informed consent. DNA was extracted using a stan-
dard phenol-chloroform method [12].
Clinical characterization of affected individuals included
funduscopy, and measurement of intraocular pressure (IOP)
with Goldmann applanation tonometry. Assessment of visual
field defects was performed with a Humphrey Visual Field
Analyzer (Carl Zeiss Humphrey Systems, Dublin, CA,
USA). Anterior insertion of the iris into the trabecular mesh-
work with prominent iris processes was observed by
gonioscopic examination. All participants were examined by
a general physician for the presence or absence of systemic
abnormalities.
Sanger sequencing
Known genes cyp1b1, Pitx2, and Foxc1 were excluded by
direct Sanger sequencing of the coding exonic and flanking
intronic regions of the respective genes. Conditions used to
amplify these genes can be provided on request.
Exome sequencing and analysis
To identify the underlying genetic cause of the disease in this
family, WES was performed using genomic DNA of the pro-
band (VI:3). Enrichment of exonic sequences was achieved by
using the SureSelectXT Human All Exon V.2 Kit (50 Mb)
(Agilent Technologies, Inc., Santa Clara, CA,USA). Sequenc-
ing was performed on a SOLiD 4 sequencing platform (Life
Technologies, Carlsbad, CA, USA). Hg19 reference genome
was aligned with the reads obtained using SOLiD LifeScope
software V.2.1 (Life Technologies).
To evaluate the pathogenicity of the variants obtained from
WES, bioinformatic analysis was performed using PhyloP
(nucleotide conservation in various species), Grantham score
(amino acid conservation), Sorting Intolerant from Tolerant
(SIFT), MutationTaster, and PolyPhen2 (http://genetics.bwh.
harvard.edu/pph2/). The presence of potential pathogenic
variants was confirmed, and segregation was checked by
PCR and Sanger sequencing. Sequencing was performed
using the Big Dye Terminator Cycle Sequencing-Ready Re-
action Kit (Applied Biosystems) on a 3130 DNA automated
sequencer (Applied Biosystems, Foster City, CA, USA) using
standard protocols.
Protein conservation
PRDM5 protein sequences from different species were
aligned to study the evolutionary conservation of the mutated
amino acid Lys293 using Vector NTI Advance 2011.
Protein structure prediction
Homology-based modeling using HOPE [13] was performed
to assess the possible structural changes in the mutant protein.
The human PDRM5 protein sequence (NM_018699, UniProt
ID: Q9NQX1) was used to predict the wild-type and mutant
protein structure.
Results
Clinical characterization
The proband (VI:3) has an affected father (V:2) and aunt
(V:1), and one affected sister (VI:5) (Fig. 1). The proband
was diagnosed at age 4 years. Ocular abnormalities included
bilateral buphthalmos, correctopia, iris atrophy, corneal opac-
ity, embryotoxon, posterior subcapsular cataract, and mild vit-
reous condensation. Funduscopy showed glaucomatous atro-
phy of the optic nerve with a cup-disc ratio (CDR) of 0.7 and
0.6 for the right and left eyes, respectively, and IOP measured
by Goldmann applanation tonometry was 32 mmHg in the
right eye and 36 mmHg for the left eye. The proband
underwent several surgeries for the right eye, including
trabeculectomy with mitomycin C (MMC) when he was
6 years old. For the left eye, cryopexy was done. At 7 years
of age, cataract surgery was performed in the right eye, follow-
ed by parsplana viterectomy with silicone oil as he developed
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retinal detachment after trauma. He has typical facial features
of ARS such as telecanthus, a broad nasal bridge,
micrognathia, and microdontia. His abdominal features in-
cluded redundant periumbilical skin. Facial dysmorphism in
individuals VI:3 and VI:5 included flattening of the mid-face,
a broad forehead, a broad nasal bridge, a thin upper lip with a
long philtrum, a protruding lower lip and a receding chin
(Fig. 2a–f). Both individuals V:1 and V:2 have hearing defects
and hip joint anomalies. None of the affected individuals have
cardiovascular defects.
Detailed clinical features of the proband and the other af-
fected individuals are summarized in Table 1.
WES variant selection and segregation analysis
of the candidate variants identified
Variants obtained by WES analysis of the proband were pri-
oritized based upon a dbSNP frequency <0.5, nucleotide and
amino acid conservation, and by in silico analyses using on-
line databases. No variants were present in the known ARS
genes PITX2 and FOXC1. Therefore, candidate variants pres-
ent in known genes involved in autosomal dominant anterior
segment defects and glaucoma [1] (Table 2) were screened for
segregation in the family.
A novel, heterozygous missense variant (c.877A>G;
p.Lys293Glu) in the PRDM5 gene was found to segre-
gate with the disease in the family (Fig. 1). The variant
(c.877A>G; p.Lys293Glu) was absent in population
matched controls and is also absent in the Exome Variant
Server database (http://eversusgs.washington.edu/EVS/)
and in the 1000 Genomes Project (http://browser.
1000genomes.org/index.html). The variant was predicted
to be pathogenic by most in silico analyses and is
present in a Cys2His2 zinc finger protein domain of
PRDM5. The lysine residue affected by the variant (c.
877A>G; p.Lys293Glu) is conserved in all species
analyzed (Fig. 3).
Protein structure prediction
Hope project analysis predicted that the lysine residue at
position Lys293 is located in the linker between two
Zn-finger domains (Fig. 4). The side chain seems to
be completely exposed to the exterior surface. The ly-
sine residue is large in size, is basic, and is positively
charged, while the mutant glutamic acid (Glu) is smaller
in size, is acidic, and is negatively charged. The wild-
type Lys residue might have been involved in electro-
static interactions with other domains of the same
Fig. 1 Segregation of a PRDM5
missense variant in a family with
Axenfeld–Rieger syndrome. The
c.877A>G; p.Lys293Glu variant
is indicated with an M, and the
wild-type allele with a +. All
affected individuals carry the
variant heterozygously, while the
unaffected individuals do not
carry the variant. The proband is
indicated with an arrow
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protein, or with other molecules in a complex. The mu-
tation introduces a residue with a sidechain that is
smaller and that carries an opposite charge, and there-
fore, the interactions may be lost.
Fig. 2 Ocular and systemic characteristics of the family with Axenfeld–
Rieger syndrome. a Eyes of the proband (VI:3) presented bilateral
buphthalmos, corectopia, polycoria, corneal edema, posterior
embryotoxon, posterior subcapsular cataract, vascularized corneal
opacity, and iris atropy patches in the left eye. b Both eyes of individual
(VI:5) showed megalocornea and posterior embryotoxon. The right eye
shows polycoria, and the left eye shows corectopia. c Facial dysmorphism
in individuals VI:3 included flattening of the mid-face, a broad forehead,
a broad nasal bridge, a thin upper lip with a long philtrum, a protruding
lower lip, and a receding chin; dmicrodontia; emicrognathia; f redundant
periumbilical skin
Table 1 Clinical evaluation of
affected family members with
Axenfeld–Rieger syndrome
Affected family members V:1 V:2 VI:3 VI:5
Current age (years) 55 60 10 20
Gender F M M F
Eye
Iris dysplasia (goniodysgenesis) + + + +
Iris hypoplasia + + + +
Glaucoma + + + +
Early development of nuclear cataract − − + −
Polycoria − − + +
Corectopia (displaced pupils) + + + +
Megacornea − − − +
Cataract − − + −
Telecanthus − − + +
Vitreous condensation + + + +
Ear
Abnormal ear, hearing defect + + − −
Nose
Broad nasal bridge + + + +
Teeth
Microdontia − + + −
Micrognathia + + + −
Abdomen
Umbilical defect (redundant periumbilical skin) + + − +
Joints
Congenital hip anomalies + + − −
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Discussion
In the current study, WES identified a novel pathogenic mis-
sense variant (c.877A>G; p.Lys293Glu) in the PRDM5 gene
segregating with the disease in a family with autosomal dom-
inant ARS. Previously, variants in the PRDM5 gene have been
identified in autosomal recessive brittle cornea syndrome
(BCS), and an enrichment of potentially pathogenic heterozy-
gous variants has been observed in keratoconus [4, 14]. In
BCS patients carrying PRDM5 mutations, a relationship was
noted between the zygosity of the mutation (homozygous/het-
erozygous) and the clinical features of the patients and age of
onset of keratoconus. Heterozygous carriers of PRDM5 mu-
tations have mildly reduced central corneal thickness, mild
keratoconus, and blue sclera compared to individuals with
homozygous mutations, who have more severe features. Indi-
viduals with BCS who carry a homozygous deletion of exons
9–14 have an earlier age of onset and more severe keratoconus
compared to individuals carrying a mutation heterozygously
[4]. A recent study proposed that heterozygous variants in
PRDM5 and ZNF469 predisposed the patients toward the de-
velopment of isolated keratoconus [15]. These studies support
that a range of ocular phenotypes are associated with variants
in the PRDM5 gene, and the current study extends the spec-
trum to autosomal dominant ARS.
PRDM5 localizes to human chromosome 4q26 and encodes
amember of the family of PRDMproteins [16]. PRDMproteins
constitute a family of transcription regulators characterized by
the presence of variable number of zinc finger repeats typically
involved in protein–DNA or protein–protein interaction [17],
and an N-terminal PR domain which shares similarity to the
SET domain of histonemethyltransferases. PRDMproteins play
a vital role in gene expression regulation, either directly or indi-
rectly by modifying the structure of chromatin, i.e., through the
intrinsic methyltransferase activity, or via the recruitment of
chromatin remodeling complexes, respectively. PRDM proteins
typically display tissue-specific patterns of expression and are
often involved in the differentiation of specific cell lineages [18].
PRDM5 is involved in the development and maintenance of
the extracellular matrix (ECM), which explains its involvement
in BCS and ARS syndromes, which represent multisystemic
connective tissue disorders. Quantitative PCR analysis of fibro-
blast RNA from BCS patients and control individuals identi-
fied significant differences in genes involved in the ECM. In
particular, genes encoding fibrillar collagens (e.g., COL4A1
andCOL11A1), connective tissue components (e.g.,HAPLN1),
and molecules regulating cell migration and adhesion (e.g.,
EDIL3 and TGFB2) were significantly downregulated. EDIL3,
HAPLN1, and COL11A1 each demonstrated a greater than 30-
fold decrease in mutant lines relative to controls [4].
A phenotypic overlap is also present to some extent in BCS
and ARS. For example, in BCS, sensorineural hearing loss is a
prominent feature and was observed in families with muta-
tions in PRDM5 described previously by Burkitt Wright
Table 2 In silico and segregation analysis of variants present in genes involved in anterior segment defects and glaucoma
Gene name cDNA change Amino acid change Phylo P Grantham distance SIFT Polyphen-2 MutationTaster Segregation
CYP1B1 c.1103G>A p.Arg368His 5.53 29 Deleterious Probably damaging Disease-causing No
MYOC c.227G>A p.Arg76Lys 0.45 26 Tolerated Benign Polymorphism No
OPTN c.964G>C p.Glu322Gln 2.79 29 Deleterious Benign Polymorphism No
COL4A1 c.1673C>T p.Ala558Val 3.03 64 Tolerated Benign Disease-causing No
WDR36 c.790A>G p.Ile264Val 1.01 29 Tolerated Benign Polymorphism No
PRDM5 c.877A>G p.Lys293Glu 2.71 56 Deleterious Benign Disease-causing Yes
B3GALTL c.1108G>A p.Glu370Lys 2.30 56 Deleterious Probably damaging Polymorphism No
The variant in PRDM5 segregating with disease is shown in bold letters
Fig. 3 PRDM5 protein sequence alignment (amino acids 283–303)
across species, indicating evolutionary conservation of lysine at position
293 in human PRDM5
Fig. 4 Secondary structure of the PRDM5 protein. The Lys residue in the
linker region between two Zn-finger domains is represented with the
green color, and the mutant Glu variant is indicated with a red color
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et al. 2011 [4]. In the current study, patients V:1 and V:2 with
ARS, a progressive sensorineural hearing loss was apparent at
young age and became severe in adulthood, especially in in-
dividual V:2. In addition to this, most of the affected individ-
uals with BCS described previously had experienced hip prob-
lems, similar to the patients V:1 and V:2 with ARS in current
study. The central corneal thickness is reduced in patients with
BCS, which is also reported previously in patients with ARS
who underwent a corneal transplantation and carry mutations
in PITX2 gene [19].
In zebrafish, Prdm5 expression was observed in specific
tissues including intestinal mucosa, ventral spinal cord and
ciliary zone by in situ hybridization [16]. In addition, Prdm5
is highly expressed in the osteoblast region of developing
bones in mice [20]. Loss of Prdm5 results in delayed ossi-
fication, involving a prominent impairment in the assembly
of fibrillar collagens. The presence of Prdm5 is therefore
vital for the proper assembly of the osteoblastic extracellular
matrix [20].
To study the role of Prdm5 during zebrafish development,
both loss of function and gain of function approaches have
been used. Two morpholino oligonucleotides were designed
to obtain a depletion of Prdm5 protein: one targeting the
region comprising the start codon (ATGmo), and one
targeting the exon1/intron1 splice site (splice blocking or
SBmo). The ATGmo induced cyclopia, while the SBmo in-
duced closer, smaller eyes and marked axial mesendodermal
defects in the jaw, heart, and blood [16]. This is in line with
the eye, jaw, and heart defects and hip anomalies seen in
individuals affected by ARS.
Other genes involved in ARS, FOXC1 [1, 6, 7], and PITX2
[5] also encode transcription factors. In addition, mutations in
transcription factor PITX3 have been identified in anterior
segment dysgenesis and congenital cataracts [5, 21]. These
studies, together with the results presented here, support an
important role for transcription factors and regulators in the
development of anterior segment defects.
Notably, nearly all homozygous PRDM5mutations detect-
ed in BCS patients disrupt the open reading frame, suggesting
that BCS is associated with loss of function of PRDM5 [4]. In
this study, a heterozygousmissense variant in the linker region
between two zinc finger domains of PRDM5was identified in
autosomal dominant ARS. Although the exact mechanism of
action of this variant is unknown, it might have a dominant
negative effect, leading to distinct ocular and extraocular fea-
tures than observed in BCS. Mutations in the PITX2 gene are
associated with autosomal dominant ARS, but both autosomal
dominant and recessive mutations have been identified in an-
other anterior segment defect (i.e., ring dermoid of the cornea)
[22]. Both PRDM5 and PITX2 are involved in Wnt signaling
pathways and are involved in the development of multiple
organs [16, 23]. This suggests that PRDM5 and PITX2 muta-
tions can lead to a spectrum of syndromic and nonsyndromic
anterior segment defects, with autosomal dominant and reces-
sive inheritance patterns. In summary, we describe a novel
association of a PRDM5 missense variant with autosomal
dominant ARS.
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